News

Naloxone 'stigma' a barrier to prescribing?

16 April 2014

Although giving out naloxone to patients at high risk of overdose sounds like a good idea, researchers who work with the drug say the stigma surrounding its use may be a barrier to wider uptake among both patients and doctors.

Patients may feel they're being treated like addicts and that their opioid prescriptions will be tempered, while doctors worry that just talking about naloxone may scare patients away, said Caleb Banta-Green, PhD, MPH, of the University of Washington in Seattle.

Please click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.